Our findings are in line with Clark et al. [27] who suggested that aCL-associated early recurrent pregnancy loss be withdrawn from the classification criteria due to inconsistent prevalence of aCL in this population and an increasing body of evidence points to the fact that this clinical manifestation of APS is distinct from late loss or early delivery with placental infarction. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.